Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis
- PMID: 9352880
- DOI: 10.1053/gast.1997.v113.pm9352880
Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis
Abstract
Background & aims: During severe pancreatitis, interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha are produced in large quantities. The aim of this study was to determine whether either one plays a more dominant role and if their detrimental effects are additive.
Methods: Necrotizing pancreatitis was induced in transgenic (-/-) knockout mice deficient in either IL-1 type 1 receptors, TNF type 1 receptors, or both IL-1 and TNF type 1 receptors. Wild-type mice served as controls. Mortality was assessed for 10 days. Additional animals were killed on days 0, 1, 2, 3, and 4 for determination of pancreatitis severity.
Results: All three knockout groups showed decreased amylase and lipase, histological score, serum IL-6, and mortality compared with wild-type groups. Animals devoid of receptors for both cytokines showed improved survival and decreased IL-6 levels compared with those devoid of either IL-1 or TNF receptors individually, yet they failed to show a further decrease in pancreatitis severity.
Conclusions: Preventing the activity of IL-1beta or TNF-alpha has a nearly identical beneficial effect on the severity and mortality of acute pancreatitis. Preventing the activity of both cytokines concurrently has no additional effect on pancreatitis severity but further attenuates the systemic stress response and is associated with an additional but modest decrease in mortality.
Comment in
-
CD4+ T cells in cerulein-induced pancreatitis.Gastroenterology. 2000 Sep;119(3):881-2. doi: 10.1053/gast.2000.17935. Gastroenterology. 2000. PMID: 11023363 No abstract available.
Similar articles
-
Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.Surgery. 1995 Jun;117(6):648-55. doi: 10.1016/s0039-6060(95)80008-5. Surgery. 1995. PMID: 7539942
-
Evidence for an unknown component of pancreatic ascites that induces adult respiratory distress syndrome through an interleukin-1 and tumor necrosis factor-dependent mechanism.Surgery. 1997 Aug;122(2):295-301; discussion 301-2. doi: 10.1016/s0039-6060(97)90021-0. Surgery. 1997. PMID: 9288135
-
Small molecule inhibition of tumor necrosis factor gene processing during acute pancreatitis prevents cytokine cascade progression and attenuates pancreatitis severity.Am Surg. 1997 Dec;63(12):1045-9; discussion 1049-50. Am Surg. 1997. PMID: 9393251
-
The potential role of therapeutic cytokine manipulation in acute pancreatitis.Surg Clin North Am. 1999 Aug;79(4):767-81. doi: 10.1016/s0039-6109(05)70042-6. Surg Clin North Am. 1999. PMID: 10470326 Review.
-
Sleep. A physiologic role for IL-1 beta and TNF-alpha.Ann N Y Acad Sci. 1998 Sep 29;856:148-159. doi: 10.1111/j.1749-6632.1998.tb08323.x. Ann N Y Acad Sci. 1998. PMID: 9917875 Review.
Cited by
-
Inflammasomes in pancreatic physiology and disease.Am J Physiol Gastrointest Liver Physiol. 2015 Apr 15;308(8):G643-51. doi: 10.1152/ajpgi.00388.2014. Epub 2015 Feb 19. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 25700081 Free PMC article. Review.
-
Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo.J Clin Invest. 2007 Jun;117(6):1502-13. doi: 10.1172/JCI30876. Epub 2007 May 24. J Clin Invest. 2007. PMID: 17525799 Free PMC article.
-
Effect of simultaneous inhibition of TNF-alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases.Ann Surg. 2004 Jul;240(1):108-16. doi: 10.1097/01.sla.0000129343.47774.89. Ann Surg. 2004. PMID: 15213626 Free PMC article.
-
Increased small bowel epithelial turnover in interleukin-1 receptor knockout mice.Ann Surg. 2000 Jul;232(1):42-5. doi: 10.1097/00000658-200007000-00006. Ann Surg. 2000. PMID: 10862193 Free PMC article.
-
Twist1 and Twist2 Induce Human Macrophage Memory upon Chronic Innate Receptor Treatment by HDAC-Mediated Deacetylation of Cytokine Promoters.J Immunol. 2019 Jun 1;202(11):3297-3308. doi: 10.4049/jimmunol.1800757. Epub 2019 Apr 26. J Immunol. 2019. PMID: 31028123 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical